153 related articles for article (PubMed ID: 21502418)
1. Next-generation pathology.
Ross JS
Am J Clin Pathol; 2011 May; 135(5):663-5. PubMed ID: 21502418
[No Abstract] [Full Text] [Related]
2. Personalized medicine and therapeutic decision-making in oncology: a commentary on key environmental issues.
Freeman RA
J Oncol Pharm Pract; 2011 Sep; 17(3):295-7. PubMed ID: 20551112
[No Abstract] [Full Text] [Related]
3. A national agenda for the future of pathology in personalized medicine: report of the proceedings of a meeting at the Banbury Conference Center on genome-era pathology, precision diagnostics, and preemptive care: a stakeholder summit.
Tonellato PJ; Crawford JM; Boguski MS; Saffitz JE
Am J Clin Pathol; 2011 May; 135(5):668-72. PubMed ID: 21502420
[No Abstract] [Full Text] [Related]
4. Personalized medicine: been there, done that, always needs work!
Murray JF
Am J Respir Crit Care Med; 2012 Jun; 185(12):1251-2. PubMed ID: 22707730
[No Abstract] [Full Text] [Related]
5. [Personalized, individualized, stratified - Thoracic oncology quo vadis?].
Thomas M; Bischoff H; Grosch H; Sianidou M; Steins M; Villalobos M
Pneumologie; 2012 Jun; 66(6):338-40. PubMed ID: 22532048
[No Abstract] [Full Text] [Related]
6. Human genome at ten: Science after the sequence.
Butler D
Nature; 2010 Jun; 465(7301):1000-1. PubMed ID: 20577184
[No Abstract] [Full Text] [Related]
7. Getting personal.
Nature; 2011 May; 473(7347):253-4. PubMed ID: 21593815
[No Abstract] [Full Text] [Related]
8. Building bridges to the future of medicine: recommendations for boosting development of novel and companion diagnostics.
Creeden J
Pharmacogenomics; 2012 Nov; 13(14):1651-9. PubMed ID: 23148640
[TBL] [Abstract][Full Text] [Related]
9. Does massively parallel DNA resequencing signify the end of histopathology as we know it?
Aparicio SA; Huntsman DG
J Pathol; 2010 Jan; 220(2):307-15. PubMed ID: 19921711
[TBL] [Abstract][Full Text] [Related]
10. Finding the true $1000 genome.
Perkel J
Biotechniques; 2013 Feb; 54(2):71-4. PubMed ID: 23384177
[No Abstract] [Full Text] [Related]
11. Heat maps, random forests, and nearest neighbors: a peek into the new molecular diagnostic world.
Heitner SB; Hollenberg SM; Colilla SA
Crit Care Med; 2010 Jan; 38(1):296-8. PubMed ID: 20023468
[No Abstract] [Full Text] [Related]
12. [Introductory remarks by chairpersons].
Kumagai S; Nobori T
Rinsho Byori; 2013 May; 61(5):419-20. PubMed ID: 23947181
[TBL] [Abstract][Full Text] [Related]
13. Sequencing's next big gamble.
Blow NS
Biotechniques; 2012 Feb; 52(2):67. PubMed ID: 22313400
[No Abstract] [Full Text] [Related]
14. [Pathology: pacemaker of advances in medicine].
Schirmacher P; Blum HE
Dtsch Med Wochenschr; 2013 May; 138(20):1043. PubMed ID: 23670258
[No Abstract] [Full Text] [Related]
15. The clinical utility of precision medicine: properly assessing the value of emerging diagnostic tests.
Shen B; Hwang J
Clin Pharmacol Ther; 2010 Dec; 88(6):754-6. PubMed ID: 21081945
[TBL] [Abstract][Full Text] [Related]
16. Changing the DNA of clinical care.
Gardner E
Health Data Manag; 2012 Sep; 20(9):22-3, 26, 28-9. PubMed ID: 22988665
[No Abstract] [Full Text] [Related]
17. Next-generation sequencing technologies for personalized medicine: promising but challenging.
Chen G; Shi T
Sci China Life Sci; 2013 Feb; 56(2):101-3. PubMed ID: 23393024
[No Abstract] [Full Text] [Related]
18. Human genome: Genomes by the thousand.
Nature; 2010 Oct; 467(7319):1026-7. PubMed ID: 20981067
[No Abstract] [Full Text] [Related]
19. [Pathology at the interface of basic and clinical research].
Carpén O; Kosma VM
Duodecim; 2013; 129(10):1080-7. PubMed ID: 23767138
[TBL] [Abstract][Full Text] [Related]
20. Genomic medicine: a question of value: despite the promise of personalized medicine, genomic testing has yet to prove its cost-effectiveness.
Nelson B
Cancer Cytopathol; 2014 Aug; 122(8):557-8. PubMed ID: 25123408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
